A significant breakthrough in cancer research is emerging with the use of mini-antibodies to reactivate damaged p53. This essential malignant protector protein is frequently disabled in several forms of cancer, causing https://bookmarkingdelta.com/story21909553/nanobodies-reactivate-tumor-suppressor-p53-the-new-pathway-for-malignant-treatment